To know or not to know: A review of behaviour and suicidal ideation in preclinical Huntington's disease

被引:61
作者
Wahlin, Tarja-Brita Robins
机构
[1] Karolinska Inst, Res & Dev Ctr Elderly Care, KC Kompetensctr, S-12524 Alvsjo, Sweden
[2] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, S-12524 Alvsjo, Sweden
关键词
Huntington's disease; predictive testing; suicidal behaviour and ideation;
D O I
10.1016/j.pec.2006.08.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: At present, the problems associated with suicidal ideation and suicide in Huntington's disease (HD), worldwide, are much the same as 2 decades ago. This study seeks to investigate the psychological complications of predictive testing in HD at risk populations. Methods: The key problems of predictive testing, fear of acquiring carrier status, psychological consequences, autonomy, and rights to know are discussed. Results: This review (1) describes psychological affect and problems of persons facing the decision to test for HD, (2) discusses suicidal ideation, behaviour, and catastrophic events associated with predictive testing, (3) assesses ethical questions raised in the genetic counselling, (4) questions whether counsellors should promote or advocate predictive testing, and finally (5) discusses what professionalism actually is in genetic counselling. Conclusion: The need for professional counselling, using a well designed protocol, and the importance of focusing on the suicide risk of participants in predictive testing programs are emphasized. Practice implications: The counsellor has an obligation to provide adequate information. The professionals should not promote nor advocate presymptomatic DNA-testing. Depression, hopelessness, anxiety, emotional distress, suicidal tendencies, and social dysfunction grading should be considered in predictive testing of HD. (c) 2006 Elsevier Ireland Ltd. All fights reserved.
引用
收藏
页码:279 / 287
页数:9
相关论文
共 87 条
[1]  
AGICH GJ, 1993, AUTONOMY LONG TERM C, P103
[2]  
ALMQVIST E, 1996, THESIS KAROLINSKA I
[3]   A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease [J].
Almqvist, EW ;
Bloch, M ;
Brinkman, R ;
Craufurd, D ;
Hayden, MR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1293-1304
[4]   High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia [J].
Almqvist, EW ;
Elterman, DS ;
MacLeod, PM ;
Hayden, MR .
CLINICAL GENETICS, 2001, 60 (03) :198-205
[5]  
[Anonymous], 1872, MED SURG REP
[6]  
[Anonymous], 2002, Huntington's disease
[7]  
Axilbund J E, 2005, J Genet Couns, V14, P235, DOI 10.1007/s10897-005-4065-z
[8]   Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes [J].
Bäckman, L ;
Robins-Wahlin, TB ;
Lundin, A ;
Ginovart, N ;
Farde, L .
BRAIN, 1997, 120 :2207-2217
[9]   ATTITUDES OF FAMILIES TO SOME ASPECTS OF HUNTINGTONS-CHOREA [J].
BARETTE, J ;
MARSDEN, CD .
PSYCHOLOGICAL MEDICINE, 1979, 9 (02) :327-336
[10]   Stress and genetic testing for disease risk [J].
Baum, A ;
Friedman, AL ;
Zakowski, SG .
HEALTH PSYCHOLOGY, 1997, 16 (01) :8-19